Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2025 is 7.85% vs -10.13% in Mar 2025
Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is 26.95% vs 178.07% in Mar 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2025 is 26.15% vs -21.66% in Mar 2025
Interest
QoQ Growth in quarter ended Jun 2025 is -2.34% vs 97.24% in Mar 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
Compare Quarterly Results Of Teva Pharmaceutical Industries Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2025 is 7.85% vs -10.13% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -2.91% vs 9.40% in Jun 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is 26.95% vs 178.07% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 130.98% vs 0.58% in Jun 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2025 is 26.15% vs -21.66% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 5.78% vs 15.25% in Jun 2024
Quarterly - Interest
QoQ Growth in quarter ended Jun 2025 is -2.34% vs 97.24% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 26.99% vs -5.88% in Jun 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
YoY Growth in quarter ended Jun 2025 has improved from Jun 2024






